Henry Ford Medical Group

Detroit, Michigan 48202

0 studies enrolling now · 2 studies all time

What they study most

Biliary Tract Cancer, Relapsed/Refractory Chronic Lymphocytic Leukemia, Richter's Syndrome, Small Lymphocytic Lymphoma, Treatment-naïve High Risk Chronic Lymphocytic Leukemia

Studies at this site

• Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome — Running, not enrolling
• Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer — Stopped early